|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Insulin glulisine,a new rapid -acting insulin analogue, displays a rapid time- action profile in obese non - diabetic subjects 显示文摘 | Becker RH Frick AD Burger F | 2005 | Exp Clin Endocrinol Diabetes2005，113，8： | 1 |
| 2 | A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog,insulin glulisine,and regular human insulin in healthy volunteers using the euglycemic clamp technique显示文摘 | BECKER RH FRICK AD BURGER F | 2005 | Exp Clin Endocrinol Diabetes2005，113，5： | 1 |
| 3 | Insulin glulisine,a new raoid-eating insulin analogue,displays a rapid time-action profile in obese non-diabetic subjects显示文摘 | BECKER RH FRICK AD BURGER F | 2005 | Exp Clin Endocrinol Diabetes2005，113，8： | 1 |
| 4 | A comparison of the steady-state pharmacokinetics and pharmacodynamics of novel rapid-acting insulin analog,insulin glulisine,and regular human insulin in healthy volunteers using the euglycemic clamp technique显示文摘 | Becker RH Frick AD Burger F | 2005 | Exp Clin Endocrinol Diabetes2005，113，5： | 1 |
| 5 | Advantage of premeal-injected insulin glulisine compared with regular humaninsulin in subjects with type 1 diabetes显示文摘 | Rave K Klein 0 Frick AD | 2006 | Diabetes Care2006，29，8： | 1 |
| 6 | Insulin glulisine, anew rapid- acting insulin analogue, displays a rapid time-action profile in obese non- diabetic subjects显示文摘 | Becker RH Frick AD Burger F | 2005 | Exp ClinEndocrinol Diabetes2005，113，8： | 1 |
| 7 | A comparison of the steady-state pharmacokinetics and pharmacodynamics of novel rapidacting insulin analog,insulin glulisine,and regular human insulin in healthy volunteers using the eu-glycemic clamp technique显示文摘 | BECKER RH FRICK AD BURGER F | 2005 | Exp Clin Endocrinol Diabetes2005，113，5： | 1 |
| 8 | Clinical pharmacokinetics and phar- macodynamics of insulin glulisine 显示文摘 | BECKER RH FRICK AD | 2008 | Clin Pharmacokinet2008，47，1： | 1 |
| 9 | Dose-response relationship of insulin glulisine in subjects with type 1 diabetes显示文摘 | Becker RH Frick AD Nosek L | | 0，，： | 1 |
| 10 | The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin 显示文摘 | Becker RH Sha S Frick AD | 2006 | Diabetes Care2006，29，2： | 1 |
| 11 | Insulin glulisine, a new rapid- acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects 显示文摘 | Becker RH Frick AD Burger F | 2005 | Exp Clin Endocrinol Diabetes2005，113，8： | 1 |
| 12 | Pharmacodynamics (PD) and pharmacokinetics (PK) of insulin glulisine compared with insulin Lispro (显示文摘 | Becker RHA Frick AD Kapitza C | 2004 | Diabetes2004，53，2： | 1 |
| 13 | Pharmacokinetic and glucodynamic profiles of insulin glulisine following subcutaneous administration at various injection sites 显示文摘 | Frick AD Becker RHA Wessels D | 2003 | Diabetes2003，52，1： | 1 |
| 14 | The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin显示文摘 | Becker RH Sha S Frick AD | 2006 | Diabetes Care2006，29，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员